GC
-
Fosun-backed Gland Pharma gets Sebi nod for Rp60bn IPO
Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has won approval for its IPO from India’s securities regulator, according to a source close to the deal.
23 Oct 2020 -
Lufax launches roadshow for $2.36bn US IPO
Lufax Holdings, a personal finance services platform, has opened books for its offering of American depositary shares (ADS). It is aiming to raise up to $2.36bn.
23 Oct 2020 -
Ant comes closer to jumbo listing as investors vie for $35bn deal
China’s Ant Group kicked off marketing for its Hong Kong and Shanghai dual listing on Thursday, the last stage before launching a possible $35bn IPO, set to be the world’s largest to date. The combined offering is already more than a third covered by onshore investors, with global buyers lining up for the rest. Addison Gong and Jonathan Breen report.
22 Oct 2020 -
JW Therapeutics opens $300m Hong Kong IPO
JW (Cayman) Therapeutics set its IPO in motion on Thursday, opening the order book for the up to HK$2.3bn ($300m) deal.
22 Oct 2020 -
GDS Holdings covers HK secondary offering
Chinese data centre operator GDS Holdings has covered the books for its Hong Kong secondary offering, just hours after launching a deal that could be worth about $1.6bn.
21 Oct 2020 -
Simcere Pharma nets $461m from top-end pricing
Simcere Pharmaceutical Group has bagged HK$3.57bn ($460.6m) from its IPO, after sealing the offer at the top end of the price guidance, according to a source familiar with the deal.
20 Oct 2020 -
Ant wins approval for Hong Kong leg of $30bn listing
Ant Group has got the go ahead from regulators for the Hong Kong portion of its dual listing, which is expected to raise around $30bn in the largest ever primary share offering globally.
20 Oct 2020 -
Shimao Services launches $1.3bn Hong Kong IPO
Shimao Services has joined the stream of Chinese property managers listing in Hong Kong this year, kicking off bookbuilding for its up to HK$10.1bn ($1.3bn) IPO.
20 Oct 2020 -
JW Therapeutics pre-markets Hong Kong IPO
JW (Cayman) Therapeutics has launched pre-deal investor education for its Hong Kong IPO, setting the final stage of the deal ahead of launch in motion.
20 Oct 2020 -
China’s SDIC recharges with $201m GDR listing
Shanghai-listed SDIC Power Holdings has priced its $200.6m London offering of Global Depository Receipts (GDRs) at the bottom of the marketed range.
19 Oct 2020
